Peter H. Krammer
Peter Heinrich Krammer (born in 1946) is a German immunologist and one of the directors of The National Center for Tumor Diseases (NCT), as well as the head of the Division Immunogenetics at the German Cancer Research Center (DKFZ) in Heidelberg. Peter H. Krammer is well known for his research and findings in apoptosis. He and his lab members discovered the CD95 receptor (also known as Fas and APO-1) and many other molecules involved in signaling through the CD95 receptor. Provided by Wikipedia-
1
-
2by Thomas Efferth, Marco Giaisi, Annette Merling, Peter H Krammer, Min Li-WeberGet full text
Published 2007-01-01
Article -
3
-
4by Kevin Bode, Fatmire Bujupi, Corinna Link, Tobias Hein, Stephanie Zimmermann, Diluka Peiris, Vincent Jaquet, Bernd Lepenies, Heiko Weyd, Peter H. KrammerGet full text
Published 2019-12-01
Article -
5by Benedikt Fritzsching, Jürgen Haas, Fatima König, Pierre Kunz, Eva Fritzsching, Johannes Pöschl, Peter H Krammer, Wolfgang Brück, Elisabeth Suri-Payer, Brigitte WildemannGet full text
Published 2011-01-01
Article -
6by Marcin M. Kamiński, Sven W. Sauer, Marian Kamiński, Silvana Opp, Thorsten Ruppert, Paulius Grigaravičius, Przemysław Grudnik, Hermann-Josef Gröne, Peter H. Krammer, Karsten GülowGet full text
Published 2012-11-01
Article -
7
-
8by Kathrin Schuldt, Cosima C Kretz, Christian Timmann, Jürgen Sievertsen, Christa Ehmen, Claudia Esser, Wibke Loag, Daniel Ansong, Carmen Dering, Jennifer Evans, Andreas Ziegler, Jürgen May, Peter H Krammer, Tsiri Agbenyega, Rolf D HorstmannGet full text
Published 2011-05-01
Article -
9by Julia Sieber‐Frank, Hans‐Jürgen Stark, Simon Kalteis, Elena‐Sophie Prigge, Richard Köhler, Carolin Andresen, Thomas Henkel, Georg Casari, Tobias Schubert, Wolfgang Fischl, Min Li‐Weber, Peter H. Krammer, Magnus vonKnebel Doeberitz, Jürgen Kopitz, Matthias Kloor, Aysel AhadovaGet full text
Published 2021-10-01
Article